Getting Out Of Biotech's Second Tier
86874
If you added all the biotech activity that industry executives and local officials across the country have forecast for the next decade, my guess is the industry would be roughly the size of the Chinese economy.
307489
Genzyme Corp. chief executive Henri A. Termeer's conference call with Wall Street on May 8, 2003, quickly turned ugly. Analysts peppered him with questions about the Cambridge biotech company's plan to buy back shares of its biosurgery division. The price, they said, was far too low.
528138
Stem Cell Sciences, an Australian biotechnology company which recently moved its headquarters to Edinburgh, Scotland, is offering scientists worldwide, unconditional access to a new embryonic stem-cell line.
394731
Sometimes bad things happen to good companies. Consider drug maker Forest Laboratories (NYSE: FRX). The company is debt-free, cash-rich, and pumping out free cash flow at $700 million a year.
750739
By Tim Mekeel, Lancaster New Era, Pa.  Feb. 23--Bill Wydra Jr. wasn't ready to leave. Not just yet.    Around him, the job fair in Thaddeus Stevens College of Technology's gym  was winding down.    Students were filing out, company brochures in hand.
134710
The boss has offered you a higher rung on the career ladder, but you're not ready to climb.
325776
The company has a much-needed solution, but it had little choice except to sell out.
145474
Looking over all the biotech stock stories I covered in 2004, I&#39;m pleased to report that I was right more than wrong. My &quot;win&quot; column does veer in the bearish direction, which is not ideal (I&#39;d prefer more
406160
The California Institute of Regenerative Medicine is losing its chief scientific officer. It's just the latest kerfuffle in a year of management missteps.
408401
Carl Icahn attempts a board shakeup at Biogen.
394781
CV Therapeutics out-licenses one of its technologies.
45047
By Sabine Vollmer, The News & Observer, Raleigh, N.C.  Feb. 13--Cornerstone BioPharma is trying to bounce back after layoffs cut the Cary company's work force in half.
70041
There are no guarantees in business -- especially when it comes to getting to the top of the ladder. Wired's How To Wiki gives you career-advancement suggestions that don't involve subterfuge and blackmail. But we can't cover everything ... without your help, so please give us your suggestions, too. It's a wiki, you know.
509369
The storm lashing big pharmaceutical companies over safety concerns about pain treatments such as Celebrex and Vioxx may actually blow some good in the direction of biotech stocks.
502113
Corporations and politicians are seeking new options for people leaving lifelong careers
592179
You don't have to be Google to challenge the way Wall Street manages initial public offerings. A little southwest Virginia biotechnology company has just gone public using the same innovative "open IPO" process as Google.
731230
The biotech mines extra value from its compound library.